Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes.

Am J Physiol Heart Circ Physiol

Dept of Internal Medicine, The Univ of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.

Published: March 2007

The purpose of this study was to characterize vascular responses and to examine mechanisms of vascular dysfunction in TallyHo mice, a new polygenic model of Type II diabetes. Responses of cerebral arterioles and carotid arteries were examined in vivo by using a cranial window and in vitro by using tissue baths, respectively. Dilatation of cerebral arterioles (baseline diameter = 33 +/- 1 micro m) in response to acetylcholine, but not to nitroprusside, was markedly reduced (P < 0.05) in TallyHo mice. Responses of cerebral arterioles to acetylcholine in TallyHo mice were restored to normal with polyethylene glycol-superoxide dismutase (100 U/ml; a superoxide scavenger). Responses to acetylcholine were also greatly impaired (P < 0.05) in the carotid arteries from TallyHo mice. Phenylephrine- and serotonin-, but not to KCl- or U46619-, induced contraction was increased two- to fourfold (P < 0.05) in carotid arteries of TallyHo mice. Responses to phenylephrine and serotonin were reduced to similar levels in the presence of Y-27632 (an inhibitor of Rho kinase; 3 micro mol/l). These findings provide the first evidence that vascular dysfunction is present in TallyHo mice and that oxidative stress and enhanced activity of Rho kinase may contribute to altered vascular function in this genetic model of Type II diabetes.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpheart.00939.2006DOI Listing

Publication Analysis

Top Keywords

tallyho mice
28
vascular dysfunction
12
dysfunction tallyho
12
model type
12
type diabetes
12
cerebral arterioles
12
carotid arteries
12
responses cerebral
8
mice responses
8
005 carotid
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!